Rensair is a specialist in air purification, protecting and enhancing lives through clean air. Our patented technology, which combines H13 HEPA filtration with germicidal UVC light, was developed to meet the strict standards of Scandinavian hospitals and is independently validated by scientific research laboratories, including Eurofins, Norconsult, Oslo University Hospital, and the Danish Technological Institute. Rensair air purification units destroy a minimum of 99.97% of airborne viruses, including coronavirus, and meet all the standards recommended by the UK SAGE committee and US EPA. We collaborate with clients to develop the optimum indoor air quality for meeting building requirements, as well as government recommendations for mitigating the risks of Covid transmission. We take into account floor plans, existing HVAC systems, occupancy rates and noise tolerance, before recommending a tailor-made solution based on our portable, modular units. Rensair has been included in Newsweek’s list of Best Infection Prevention Products 2021. To make the list, a selection committee evaluated the product against several criteria: effectiveness; safety; successful real-world implementation; the quality of research studies demonstrating the product's effectiveness; and the stability of the company (to support future implementations). With operations in the UK, Europe, the USA and Asia, Rensair’s mission is to provide clean air for every space: from hospitals, dental practices, schools and gymnasia, to hospitality venues, hotels, restaurants and retail outlets.